Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-10-13FDA Approved: LITHOBID — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Lithobid (lithium carbonate) filed by ANI Pharmaceuticals, Inc.
-
FDA approval · 2022-10-13FDA Approved: LITHIUM CARBONATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for lithium carbonate from Hikma Pharmaceuticals USA Inc., authorizing changes to the existing N…
-
FDA approval · 2022-10-13FDA Approved: LITHIUM CARBONATE ER — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for Lithium Carbonate ER from Glenmark Pharmaceuticals, authorizing an extended-release formulat…
-
FDA approval · 2022-10-13FDA Approved: LITHIUM CARBONATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for lithium carbonate submitted by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2022-10-13FDA Approved: LITHIUM CARBONATE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for lithium carbonate filed by Rising Pharma Holdings, Inc. (ANDA205663).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-10-06FDA Approved: LURASIDONE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental abbreviated new drug application for lurasidone hydrochloride, enabling marketing of the ge…
-
FDA approval · 2022-10-06FDA Approved: CARBAMAZEPINE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' generic carbamazepine under Original Application ANDA214277.
-
FDA approval · 2022-09-20FDA Approved: ARIPIPRAZOLE — Supplemental Application (Dr.Reddys Laboratories Inc)
FDA approved a supplemental application for ARIPIPRAZOLE by Dr. Reddy's Laboratories Inc. under the ANDA, authorizing a modification to the …
-
FDA approval · 2022-09-15FDA Approved: ZIPRASIDONE MESYLATE — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved the original Abbreviated New Drug Application for ziprasidone mesylate from Novadoz Pharmaceuticals LLC, a generic version of z…
-
FDA approval · 2022-09-09FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (MAJOR PHARMACEUTICALS)
FDA approves Major Pharmaceuticals' original application for lurasidone hydrochloride (generic).
-
FDA approval · 2022-08-24FDA Approved: QUETIAPINE — Original Application (Solco Healthcare US, LLC)
FDA approves Solco Healthcare's original application for a generic quetiapine product (quetiapine fumarate tablets), enabling a generic vers…
-
FDA approval · 2022-08-22FDA Approved: CARBAMAZEPINE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved the Original Application for generic carbamazepine from Unichem Pharmaceuticals (USA), Inc.
-
FDA approval · 2022-08-18FDA Approved: CARBAMAZEPINE — Original Application (Northstar Rx LLC)
FDA approved the original generic application for Carbamazepine from Northstar Rx LLC, authorizing a generic version of the anticonvulsant. …
-
FDA approval · 2022-08-15FDA Approved: QUETIAPINE — Original Application (BluePoint Laboratories)
FDA approved a generic version of quetiapine from BluePoint Laboratories under an Original Application (ANDA 215478).
-
FDA approval · 2022-07-27FDA Approved: LAMOTRIGINE — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved a supplemental application for the lamotrigine generic product from Alembic Pharmaceuticals Limited, reflecting a regulator…
-
FDA approval · 2022-07-18FDA Approved: LAMOTRIGINE — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
The FDA approved a supplemental application for a generic lamotrigine product from Jubilant Cadista Pharmaceuticals Inc.
-
FDA approval · 2022-07-13FDA Approved: OLANZAPINE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for olanzapine filed by Torrent Pharmaceuticals Limited.
-
FDA approval · 2022-07-08FDA Approved: LAMOTRIGINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Lamotrigine by Aurobindo Pharma Limited, enabling a generic lamotrigine product.
-
FDA approval · 2022-07-08FDA Approved: OLANZAPINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application from Apotex Corp. for olanzapine, authorizing a generic olanzapine product.
-
FDA approval · 2022-06-30FDA Approved: LAMOTRIGINE KIT — Supplemental Application (OWP Pharmaceuticals, Inc.)
FDA approved a supplemental application for the Lamotrigine Kit from OWP Pharmaceuticals, authorizing the lamotrigine kit formulation.
-
FDA approval · 2022-06-16FDA Approved: QUETIAPINE FUMARATE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic quetiapine fumarate under an Original Application. The product will be used for the same indica…
-
FDA approval · 2022-06-10FDA Approved: LAMOTRIGINE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Lamotrigine from Zydus Pharmaceuticals USA Inc., indicating a post-approval modification to …
-
FDA approval · 2022-05-27FDA Approved: ARIPIPRAZOLE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for aripiprazole filed by Amneal Pharmaceuticals LLC (generic aripiprazole).
-
FDA approval · 2022-04-26FDA Approved: QUETIAPINE — Original Application (Solco Healthcare U.S., LLC)
The FDA approved the original application for generic quetiapine from Solco Healthcare U.S., LLC.
-
FDA approval · 2022-04-05FDA Approved: IGALMI — Original Application (BioXcel Therapeutics, Inc.)
FDA approves IGALMI (dexmedetomidine) by BioXcel Therapeutics for the acute treatment of agitation in adults with schizophrenia or bipolar I…